2Edmunds LH Jr.Hastings lecture.Breaking the blood-biomaterial barrier[J].ASAIO J,1995,41(4):824-830.
3Baksaas ST,Videm V,Fosse E,et al.In vitro evaluation of new surface coatings for extracorporeal circulation[J].Perfusion,1999,14(1):11-19.
4Hioki I,Nishikawa M,Onoda K,et al.A heparin-coated circuit maintains platelet aggregability in response to shear stress in an in vitro model of cardiopulmonary bypass[J].Thromb Haemost,1998,80(3):437-442.
5Videm V,Nilsson L,Venge P,et al.Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass[J].Artif Organs,1991,15(2):90-95.
6Zwaal RF,Comfurius P,van Deenen LL.Membrane asymmetry and blood coagulation[J].Nature,1977,268(5618):358-360.
7Stammers AH,Christensen KA,Lynch J,et al.Quantitative evaluation of heparin-coated versus nonheparin-coated bypass circuits during cardiopulmonary bypass[J].J Extra Corpor Technol,1999,31(3):135-141.
8Mangoush O,Purkayastha S,Haj-Yahia S,et al.Heparin-bonded circuits versus nonheparin-bonded circuits:an evalutation of their effect on clinical coutcomes[J].Eur J Cardiothorac Surg,2007,31(6):1058-1069.
9Ovrum E,Tangen G,Oystese R,et al.Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations[J].J Thorac Cardiovasc Surg,2001,121(2):324-330.
10Ovrum E,Mollnes TE,Fosse E,et al.Complement and granulocyte activation in two different types of heparinized extracorporeal circuits[J].J Thorac Cardiovasc Surg,1995,110(6):1623-1632.
10Dalton HJ.Outcome following pediatric ECMO[A].In:Zwischenberger JB,Steinhorn RH,Bartlett RH,editors.ECMO:extracorporeal cardiopulmonary support in critical care[M].2nd ed.Ann Arbor,Mich'ELSO,2000.481-493.
